SUBSTRATA MAIN PAGE


Clostridium symbiosum

RANK: Species

TAXONOMY: Terrabacteria group -> Firmicutes -> Clostridia -> Clostridiales -> Lachnospiraceae -> Lachnoclostridium -> Clostridium symbiosum

OVERVIEW:

[Launay A, Ballard SA, Johnson PD, Grayson ML, Lambert T (2006) Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother 50:1054–1062]We describe a fatal case of Clostridium symbiosum bacteremia in a 70-year-old man with metastatic colon cancer. Our report is the first, in the world literature, of human infection caused by this microorganism.[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC516307/]Synonyms : JCM 1297, DSM 934, Clostridium symbiosum, Bacteroides symbiosus, ATCC. Direct sub-taxa of Clostridium symbiosum: Clostridium symbiosum ATCC 14940, Clostridium symbiosum WAL-14163, Clostridium symbiosum WAL-14673 

This species has been identified as a resident in the human gastrointestinal tract based on the phylogenetic framework of its small subunit ribosomal RNA gene sequences.[PMC 4262072]

COGEM
COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Clostridium symbiosum ranks on this scale:


TAGS
Keystone
Core species
Type species
Pathogen
Dysbiosis associated
Flora/ commensal
Gut associated
Probiotic
Leanness
Obesity
Skin microbiome
Fecal distribution
Oral microbiome
Vaginal microbiome
Butyrate producer
Catalase producer
Histamine producer
Food fermenter
Amylolytic
Propionate producer
Nitrifying
Biofilm producer
INTERACTIONS
KEGG PATHWAYS

CLUSTERS WITH
METABOLOMICS       
NUTRIENTS/ SUBSTRATES

ENDPRODUCTS
  • Propionate
  • ANTIBIOTIC RESISTANCE   BIOFILM FORMERS   COGEM PATHOGENICITY   

    SUBSTRATA ™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015, 2016, 2017, 2018, 2019, 2020 ALL RIGHTS RESERVED.    |    DEVELOPER BLOG     |